IP Library › Granted Patent US 8,022,217
Granted Patent B2
US 8,022,217 · App. 12/374,089 · Granted Sep 20, 2011

Compounds suitable as modulators of HDL

Assignee: Cadila Healthcare Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,022,217
App. No.
12/374,089
Granted
Sep 20, 2011
Kind
B2
Abstract

Disclosed herein in the embodiments of the present invention are the compounds suitable as modulators of HDL having general formula (1), novel intermediates involved in their synthesis, their pharmaceutically acceptable salts and pharmaceutical compositions containing them. The present invention also relates to a process of preparing compounds of general formula (1), their tautomeric forms, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and novel intermediates involved in their synthesis.

Claims (66)

1. Compound represented by the formula (1)

wherein

X is selected from C═O; R 1 and R 2 may, together along with the atoms to which they are attached, form a 6 membered heterocyclic ring having 1 heteroatoms selected from N; R 3 at each occurrence is independently an H atom; R 4 is selected from an optionally substituted C (3-13) carbocyclic or a heterocyclic residue; R 5 at each occurrence is independently an H atom; R 6 is selected from hydrogen, optionally substituted C (3-13) carbocyclic or a heterocyclic residue; R 7 at each occurrence is independently selected from the group consisting of hydrogen, halogen, optionally substituted groups selected from C (1-6) alkyl, lower halo C (1-6) alkyl groups; and m=1-2, n=2, p=0-3.

2. A compound as claimed in claim 1 wherein, “carbocycle or carbocyclic residue” include, phenyl, naphthyl, indanyl, or tetrahydronaphthyl (tetralin).

3. A compound as claimed in claim 1 wherein, “heterocycle or heterocyclic system” include, but are not limited to, benzoxazolyl, tetrahydroisoquinolinyl, tetrahydroquinolinyl.

4. A compound as claimed in claim 1 wherein X is selected from C═O; R 1 and R 2 may together along with the atoms to which they are attached form a 6 membered heterocyclic ring having 1-heteroatoms selected from N; R 3 & R 5 independently represent H; R 4 is selected from an optionally substituted aryl group; R 5 is H; R 6 is selected from an optionally substituted aryl group; R 7 at each occurrence is independently selected from the groups comprising of hydrogen, halogen, optionally substituted groups selected from C (1-3) alkyl group.

5. A compound as claimed in claim 1 , wherein R 1 & R 2 together forms an optionally substituted heterocyclic groups selected from 1,2,3,4-tetrahydro-quinoline.

6. A compound as claimed in claim 1 wherein R 4 & R 6 are each an optionally substituted phenyl group.

7. A compound as claimed in claim 1 further comprising:

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(4-fluoro-phenyl)-ethyl)-amide;

6-Trifluoromethyl-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(4-fluoro-phenyl)-ethyl)-amide;

5-Trifluoromethyl-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(4-fluoro-phenyl)-ethyl)-amide;

5-Chloro-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(4-fluoro-phenyl)-ethyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (3,5-bis-trifluoromethyl-benzyl)-(2-(4-fluoro-phenyl)-ethyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(3-phenoxy-phenyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(3-chloro-phenyl)-ethyl)-amide;

6-Methyl-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(4-fluoro-phenyl)-ethyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (2-(4-fluoro-phenyl)-ethyl)-(4-trifluoromethyl-benzyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (4-diethylamino-benzyl)-(2-(4-fluoro-phenyl)-ethyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(4-methoxy-phenyl)-ethyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(2,6-dichloro-phenyl)-ethyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(4-fluoro-benzyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(3,4-dichloro-phenyl)-ethyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(3-chloro-benzyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(2-fluoro-phenyl)-ethyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (2-(3,5-bis-trifluoromethyl-phenyl)-ethyl)-(4-tert-butyl-benzyl)-amide;

6-Fluoro-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(4-fluoro-phenyl)-ethyl)-amide;

6-Chloro-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(4-fluoro-phenyl)-ethyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-phenethyl-amide;

6-Bromo-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(3-chloro-phenyl)-ethyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(4-diethylamino-phenyl)-ethyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (2-(3,4-dichloro-phenyl)-ethyl)-(4-methyl-benzyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (2-(4-bromo-phenyl)-ethyl)-(4-tert-butyl-benzyl)-amide;

6-Methyl-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(3,4-dichloro-phenyl)-ethyl)-amide;

6-Fluoro-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(3,4-dichloro-phenyl)-ethyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (2-(4-fluoro-phenyl)-ethyl)-naphthalen-2-ylmethyl-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(3,4-dichloro-phenyl)-ethyl)-amide hydrochloride;

6-Chloro-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(4-fluoro-phenyl)-ethyl)-amide hydrochloride;

6-Methyl-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(3,4-dichloro-phenyl)-ethyl)-amide hydrochloride;

6-Fluoro-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(3,4-dichloro-phenyl)-ethyl)-amide hydrochloride;

6-Chloro-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (2-benzo(1 ,3)dioxol-5-yl-ethyl)-(4-tert-butyl-benzyl)-amide;

6-Chloro-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(3,4-dichloro-phenyl)-ethyl)-amide hydrochloride;

6-Chloro-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(3,4-dichloro-phenyl)-ethyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-naphthalen-2-yl-ethyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-naphthalen-1-yl-ethyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (2-benzo(1,3)dioxo1-5-yl-ethyl)-(4-tert-butyl-benzyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-indan-5-yl-amide;

6-Chloro-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(3,4-difluoro-phenyl)-ethyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(3,4-difluoro-phenyl)-ethyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(4-hydroxy-phenyl)-ethyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(3,4-dimethoxy-phenyl)-ethyl)-amide;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(3-(4-fluoro-phenyl)-propyl)-amide;

6-Chloro-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(4-chloro-3-fluoro-phenyl)-ethyl)-amide;

6-Chloro-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(3,5-dimethoxy-phenyl)-ethyl)-amide;

6-Chloro-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(3,4-difluoro-phenyl)-ethyl)-amide, hydrochloride;

6-Chloro-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(3-(3,4-dichloro-phenyl)-propyl)-amide hydrochloride salt;

1,2,3,4-Tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(4-trimethylsilanyloxy-phenyl)-ethyl)-amide;

6-Chloro-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(4-chloro-3-fluoro-phenyl)-ethyl)-amide hydrochloride salt;

6-Chloro-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-(2-(3-chloro-4-fluoro-phenyl)-ethyl)-amide hydrochloride salt;

6-Chloro-1,2,3,4-tetrahydro-quinoline-8-carboxylic acid 4-tert-butyl-benzylamide.

8. A compound as claimed in claim 2 wherein R 1 & R 2 together form an optionally substituted heterocyclic groups selected from 1,2,3,4-tetrahydro-quinoline.

9. A compound as claimed in claim 3 wherein R 1 & R 2 together form an optionally substituted heterocyclic groups selected from 1,2,3,4-tetrahydro-quinoline.

10. A compound as claimed in claim 2 wherein R 4 & R 6 are each an optionally substituted phenyl group.

11. A compound as claimed in claim 3 wherein R 4 & R 6 are each an optionally substituted phenyl group.

12. A compound as claimed in claim 4 wherein R 4 & R 6 are each an optionally substituted phenyl group.

13. A compound as claimed in claim 5 wherein R 4 & R 6 are each an optionally substituted phenyl group.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2009
From: THOMBARE, PRAVIN S.; LOHRAY, BRAJ BHUSHAN; LOHRAY, VIDYA BHUSHAN; PATEL, PANKAJ RAMANBHAI
To: CADILA HEALTHCARE LIMITED
Reel/Frame 022221/0164 →
Priority Claims (1)
IN 1213/MUM/2006 · Jul 31, 2006 · national
Continuity (1)
Related Publication 20090171091A1 · Jul 2, 2009